Targeting MTAP increases PARP inhibitor susceptibility in triple-negative breast cancer through a feed-forward loop

Triple-negative breast cancer (TNBC) represents the most malignant subtype of breast cancer. The clinical application of PARP inhibitors (PARPi) is limited by the low frequency of BRCA1/2 mutations in TNBC. Here, we identified that MTAP deletion sensitized genotoxic agents in our clinical cohort of...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of clinical investigation Vol. 135; no. 13; pp. 1 - 18
Main Authors: Zeng, Xiangyu, Zhao, Fei, Tu, Xinyi, Zhang, Yong, Yang, Wen, Hou, Jing, Jiang, Qi, Zhu, Shouhai, Wu, Zheming, Hao, Yalan, Zhang, Lingxin, Weinshilboum, Richard M., Tao, Kaixiong, Wang, Liewei, Lou, Zhenkun
Format: Journal Article
Language:English
Published: United States American Society for Clinical Investigation 01.07.2025
Subjects:
ISSN:1558-8238, 0021-9738, 1558-8238
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first